GW-559090

DB06508ExperimentalSmall molecule

Investigated for use/treatment in asthma and allergic rhinitis.

Chemical structure of GW-559090
Primary indication
Investigated for use/treatment in asthma and allergic rhinitis.Curator reviewed
Formula / weight
C31H40N4O8 · 596.681 g/mol (avg)
Code names
GW-559090 · GW-559090(FREE ACID)

Resolves to

Compound
UNIIH9W4YH429KCAS278598-52-0
Structure
InChIKeyRZMCXMNNXGCFQG-DQEYMECFSA-NSMILESCC(C)C[C@H](NC(=O)COC1=CC=CC=C1C)C(=O)N[C@@H](CC1=CC=C(OC(=O)N2CCC(CC2)C(N)=O)C=C1)C(O)=O
Targets
P08648ITGA5

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with GW-559090, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In